"It appears that the defendant has kept the pack of the plaintiff in front while preparing its pack," the court said.

Roche's bid to block a generic SMA drug risks public health by limiting affordable access, say patient groups, highlighting high costs and patent issues.

Roche, a Swiss multinational healthcare company, is seeking a permanent injunction against Natco Pharma to prevent the introduction of a generic version of Risdiplam, a Spinal Muscular Atrophy (SMA) ...

Public health groups are challenging Roche's attempt to block a generic version of its expensive Spinal Muscular Atrophy drug ...

Health groups and patient advocates are raising concerns over patent monopolies on rare disease drugs in India. They argue ...

Clear geographic boundaries in a statutory injunction gave police much-needed power to enforce bylaws during Freedom Convey ...

Roche, a Swiss multinational healthcare company, is seeking a permanent injunction against Natco Pharma to prevent the ...

Patients with rare diseases in India, like Saifullah Khalidi with spinal muscular atrophy (SMA), struggle to afford ...

Patient advocates push for generic drug production to treat rare diseases, facing patent barriers and high costs.

In relation to a copyright suit filed by Star Channels, the Delhi High Court has restrained a 'rogue app' and related ...

The company, which processes food waste into animal feed, is facing a lawsuit from the attorney general's office.

A federal district court granted state Attorney General Michele Henry’s motion for a temporary restraining order to pause the ...